IP Library Granted Patent US 8,486,143
Granted Patent B2
US 8,486,143 · App. 12/649,913 · Granted Jul 16, 2013

Mechanically competent scaffold for ligament and tendon regeneration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,486,143
App. No.
12/649,913
Granted
Jul 16, 2013
Kind
B2
Abstract

A multi-region device for repair, regeneration or reconstruction in articular tissue injury such as torn ligaments and tendons is provided. The device comprises at least one degradable material and biocompatible non-degradable polymeric fiber-based material, in a three-dimensional braided scaffold. The two end sections are designed for attachment of the device at the site of implantation and are designed to allow bone cell ingrowth, and one or more middle regions are designed to allow ligament or tendon cell ingrowth.

Claims (39)

1. A device for replacement or regeneration of articular tissue comprising

polymeric fibers degrading at between nine and twelve months following implantation, and

polymeric fibers not degrading following implantation in less than one year,

wherein the polymeric fibers are braided into a three-dimensional braided scaffold to form two end sections for attachment of the device at a site of implantation and at least one middle section between the end sections, wherein the polymeric braid of the middle section is more porous than the polymeric braid of the end sections and allows in-growth of connective tissue, and wherein the polymeric braids of the end sections are attachable to bone, have a porosity less than 50% and allow for ingrowth of bony tissue,

wherein the device has a peak load strength range from 500 to 3200 N and provides articular tissue function at the site of implantation as tissue integrates into the device.

2. The device of claim 1 produced by a three-dimensional rotary braiding method or row and column method.

3. The device of claim 1 having an initial stiffness range of 200 to 700 N/mm.

4. The device of claim 1 wherein the number of fibers per bundle is in the range of 10 to 60 and the number of bundles per braid is in the range of 16 to 64.

5. A device for replacement or regeneration of articular tissue comprising

polymeric fibers degrading at between nine and twelve months following implantation, and

polymeric fibers not degrading following implantation in less than one year,

wherein the polymeric fibers are braided into a three-dimensional braided scaffold to form two end sections for attachment of the device at a site of implantation and at least one middle section between the end sections, wherein the polymeric braid of the middle section degrades more rapidly or is more porous than the polymeric braid of the end sections and allows in-growth of connective tissue, and the polymeric braids of the end sections are attachable to bone and allow for ingrowth of bony tissue,

wherein the polymeric braid of the middle section of the device has a porosity between 50 and 70%, and pores between 177 μm and 250 μm in diameter, and

wherein the device has a peak load strength range from 500 to 3200 N and provides articular tissue function at the site of implantation as tissue integrates into the device.

6. The device of claim 1 , wherein the middle section differs from the endsections in size, braiding angle, or porosity.

7. The device of claim 1 wherein at least 70% of the polymeric fibers are degradable in less than one year.

8. The device of claim 7 , wherein between 70 and 90% of the polymeric fibers are degradable in less than one year.

9. The device of claim 1 wherein the degradable polymer fibers are made up of polymers selected from the group consisting of poly(L-lactic acid (PLLA), poly(DL-lactic acid (PLA), poly(DL-lactic-co-glycolic acid)(PLGA), polyorthoesters, polyanhydrides, polyphosphazenes, polycaprolactones, polyhydroxyalkanoates, biodegradable polyurethanes, polyanhydride-co-imides, polypropylene fumarates, polydiaxonane, polysaccharides, collagen, silk, chitosan, and celluloses.

10. The device of claim 1 wherein the non-degradable polymer fibers are made up of polymers selected from the group consisting of polyethylene terephthalate (PET), polyetheretherketone (PEEK), polytetrafluoroethylene (PTFE), polyester, polyethylene, polyamide, polyimide, polyurethane, polybutadiene, polybutylene, and polypropylene.

11. The device of claim 1 , wherein the device is seeded with cells, ingrowth of which is supported by the scaffold.

12. The device of claim 11 wherein the cells are selected from the group consisting of mesenchymal cells, cells generating mesenchymal cells, fibroblasts, pluripotent stem cells, and multipotent stem cells.

13. A method for repairing, regenerating, replacing or reconstructing a damaged tendon or ligament in a patient comprising implanting at a site of a damaged tendon or ligament a device for replacement or regeneration of articular tissue comprising

polymeric fibers degrading at between nine and twelve months following implantation, and

polymeric fibers not degrading following implantation in less than one year,

wherein the polymeric fibers are braided into a three-dimensional braided scaffold to form two end sections for attachment of the device at a site of implantation and at least one middle section between the end sections, wherein the polymeric fiber braid of the middle section is more porous than the polymeric fiber braids of the end sections and allows in-growth of connective tissue, and the polymeric braid end sections are attachable to bone, have a porosity less than 50% and allow for ingrowth of bony tissue,

wherein the device has a peak load strength range from 500 to 3200 N and provides articular tissue function at the site of implantation as tissue integrates into the device.

14. A kit comprising

a device for replacement or regeneration of articular tissue comprising

polymeric fibers degrading at between nine and twelve months following implantation, and

polymeric fibers not degrading following implantation in less than one year,

wherein the polymeric fibers are braided into a three-dimensional braided scaffold to form two end sections for attachment of the device at a site of implantation and at least one middle section between the end sections, wherein the polymeric fiber braid of the middle section is more porous than the polymeric fiber braids of the end sections and allows in-growth of connective tissue, and the polymeric braid end sections are attachable to bone, have a porosity less than 50% and allow for ingrowth of bony tissue,

wherein the device has a peak load strength range from 500 to 3200 N and provides articular tissue function at the site of implantation as tissue integrates into the device, and means for attachment.

15. A method of making a device for replacement or regeneration of articular tissue

comprising braiding a three-dimensional scaffold comprising

polymeric fibers degrading at between nine and twelve months following implantation, and

polymeric fibers not degrading following implantation in less than one year,

wherein the polymeric fibers are braided into a three-dimensional braided scaffold to form two end sections for attachment of the device at a site of implantation and at least one middle sections between the end sections, wherein the polymeric fiber braid of the middle section is more porous than the polymeric braid of the end sections and allows in-growth of connective tissue, and the polymeric braid end sections are attachable to bone, have a porosity less than 50% and allow for ingrowth of bony tissue,

wherein the device has a peak load strength range from 500 to 3200 N and

provides articular tissue function at the site of implantation as tissue integrates into the device.

Assignments (1)
SECURITY INTEREST Recorded Jul 21, 2025
From: CONMED CORPORATION; BIOREZ, INC.; BUFFALO FILTER LLC; IN2BONES USA, LLC; LINVATEC CORPORATION; SURGIQUEST, INC.; VIKING SYSTEMS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072097/0762 →